U. Of California Debates Its Role In Managing Federal Weapons Labs

Does university management foster free inquiry at national weapons labs, or does it inhibit the university's own academic freedom? That's the question University of California Regents will face in September when they vote on a proposed renewal of the university's current contract to manage Los Alamos and Lawrence Livermore national laboratories for the Department of Energy. Although opponents of the nuclear arms race have long fought the university's 40-year oversight of the labs, faculty oppo

Written byMarcia Clemmitt
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Does university management foster free inquiry at national weapons labs, or does it inhibit the university's own academic freedom? That's the question University of California Regents will face in September when they vote on a proposed renewal of the university's current contract to manage Los Alamos and Lawrence Livermore national laboratories for the Department of Energy.

Although opponents of the nuclear arms race have long fought the university's 40-year oversight of the labs, faculty opposition appears to have hardened since the last vote by the regents five years ago to extend the contract.

"It's never been documented that more open discussion takes place at Los Alamos and Livermore than at labs otherwise managed," says physicist Walter Kohn, one of six members of an eight-person faculty committee that voted to sever the ties, "and there are flagrant cases where freedom of expression was denied at UC-managed labs." A recent vote showed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies